Medical Articles 5/6
Posted by rob on May 6, 2009 under Uncategorized | 
Be the First to Comment
Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results.
Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.
BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.
Add A Comment
You must be logged in to post a comment.